Literature DB >> 405165

The mutual clonal origin of the lymphoplasmocytic and lymphoma cell in alpha-heavy chain disease.

B Ramot, M Levanon, Y Hahn, N Lahat, C Moroz.   

Abstract

Biosynthetic studies in alpha-heavy chain disease were performed on the gut tumour which was composed mainly of lymphoplasmocytic cells and on the mesenteric lymph node tumour composed mainly of immunoblasts. The gut tumour cells synthesised alpha-heavy chains and secreted them during 2-5 hr culture, whereas the lymph node tumour cells synthesized alpha-heavy chains which were shed into the culture medium only after 20 hr. These chains were shown to be present on the surface of the immunoblastic tumour cells by enzymatic radioiodination. Both the surface and the secreted alpha-heavy chain of the lymph node and gut tumour were found to be smaller than the alpha-heavy chain of myeloma proteins. These results suggest that the lymphoblasmocytic and the immunoblastic tumour cells originate from the same defective clone.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 405165      PMCID: PMC1540932     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  MALABSORPTION SYNDROME IN LYMPHOMA OF SMALL INTESTINE. A STUDY OF 13 CASES.

Authors:  B RAMOT; N SHAHIN; J J BUBIS
Journal:  Isr J Med Sci       Date:  1965-03

2.  Polyribosomal synthesis and assembly of the H and L chains of gamma globulin.

Authors:  A L Shapiro; M D Scharff; J V Maizel; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1966-07       Impact factor: 11.205

3.  Alpha-chain disease: a new immunoglobulin abnormality.

Authors:  M Seligmann; F Danon; D Hurez; E Mihaesco; J L Preud'homme
Journal:  Science       Date:  1968-12-20       Impact factor: 47.728

4.  The pathology of so-called Mediterranean abdominal lymphoma with malabsorption.

Authors:  H Rappaport; B Ramot; N Hulu; J K Park
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

5.  [Mediterranean lymphoma with alpha chain disease. Triple chemical anatomic and immunological remission].

Authors:  J Rogé; P Druet; C Marche
Journal:  Pathol Biol (Paris)       Date:  1970-10

6.  Surface immunoglobulin of mouse thymus cells and its in vitro biosynthesis.

Authors:  C Moroz; N Lahat
Journal:  Cell Immunol       Date:  1974-09       Impact factor: 4.868

7.  Alpha chain disease.

Authors:  M Seligmann; E Mihaesco; B Frangione
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

8.  Immunochemical studies in four cases of alpha chain disease.

Authors:  M Seligmann; E Mihaesco; D Hurez; C Mihaesco; J L Preud'homme; J C Rambaud
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

Review 9.  Malabsorption due to lymphomatous disease.

Authors:  B Ramot
Journal:  Annu Rev Med       Date:  1971       Impact factor: 13.739

10.  Five cases of alpha chain disease.

Authors:  W F Doe; K Henry; J R Hobbs; F A Jones; C E Dent; C C Booth
Journal:  Gut       Date:  1972-12       Impact factor: 23.059

  10 in total
  6 in total

1.  Light chains in Mediterranean lymphoma.

Authors:  P G Isaacson; S K Price
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

2.  Abnormal chromosomal marker (D14 q+) in a patient with alpha heavy chain disease.

Authors:  U Gafter; E Kessler; F Shabtay; P Shaked; M Djaldetti
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

3.  Morphology of lymphatic cells and of their derived tumours.

Authors:  F Rilke; S Pilotti; A Carbone; L Lombardi
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

4.  Celluar immunoglobulins in human gamma- and alpha-heavy chain diseases.

Authors:  J L Preud'homme; J C Brouet; M Seligmann
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

5.  Immunodiagnosis of alpha chain disease.

Authors:  W F Doe; F Danon; M Seligmann
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

6.  Alpha heavy chain disease lacking secretory alpha chain, with cobblestone appearance of the small intestine and duodenal ulcer demonstrated by endoscopy.

Authors:  T Hibi; H Asakura; K Kobayashi; Y Munakata; S Kano; M Tsuchiya; T Teramoto; Y Uematsu
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.